The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

S PolG HaourHélène FontaineC DorivalV Petrov-SanchezM BourliereJ CapeauP CarrieriD LarreyC LarsenP MarcellinJ-M PawlostkyPierre NahonF ZoulimPatrice CacoubV de LedinghenP MathurinF NegroG-P PageauxY YazdanpanahL WittkopJ-P ZarskiF Carratnull null

Published in: Alimentary pharmacology & therapeutics (2017)

HCV coinfection harmfully affects liver fibrosis in HBV patients, while decompensated cirrhosis is increased in coinfected patients compared with HBV- or HCV-monoinfected patients. HCV treatment is as safe and effective in coinfected as monoinfected patients and should be considered following the same rules as HCV monoinfected patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis c virus
prognostic factors
heart failure
atrial fibrillation
patient reported
smoking cessation